LpxC inhibitors as new antibacterial agents and tools for studying regulation of lipid A biosynthesis in Gram-negative pathogens.
about
Regulated Control of the Assembly and Diversity of LPS by Noncoding sRNAsEvolution of the Pseudomonas aeruginosa mutational resistome in an international Cystic Fibrosis cloneInhibition of LpxC Increases Antibiotic Susceptibility in Acinetobacter baumanniiMutant Alleles of lptD Increase the Permeability of Pseudomonas aeruginosa and Define Determinants of Intrinsic Resistance to Antibiotics.Transport of lipopolysaccharide to the Gram-negative bacterial cell surface.Translational deficiencies in antibacterial discovery and new screening paradigms.Curative Treatment of Severe Gram-Negative Bacterial Infections by a New Class of Antibiotics Targeting LpxC.LpxC inhibitors: a patent review (2010-2016).New molecules and adjuvants in the treatment of infections by Acinetobacter baumannii.Antibacterial Drug Discovery Targeting the Lipopolysaccharide Biosynthetic Enzyme LpxC.Using bacterial genomes and essential genes for the development of new antibiotics.Structure, inhibition, and regulation of essential lipid A enzymes.Susceptibility of Clinical Isolates of Burkholderia pseudomallei to a Lipid A Biosynthesis Inhibitor.High susceptibility of MDR and XDR Gram-negative pathogens to biphenyl-diacetylene-based difluoromethyl-allo-threonyl-hydroxamate LpxC inhibitors.Genomics and Susceptibility Profiles of Extensively Drug-Resistant (XDR) Pseudomonas aeruginosa from Spain.In Vitro and In Vivo Efficacy of an LpxC Inhibitor, CHIR-090, Alone or Combined with Colistin against Pseudomonas aeruginosa Biofilm.Expanding the paradigm for the outer membrane: Acinetobacter baumannii in the absence of endotoxin.Genetic mechanisms of Coxiella burnetii lipopolysaccharide phase variation.The Biosynthesis of Lipooligosaccharide from Bacteroides thetaiotaomicron.Lipid A Has Significance for Optimal Growth of Coxiella burnetii in Macrophage-Like THP-1 Cells and to a Lesser Extent in Axenic Media and Non-phagocytic Cells.
P2860
Q26776000-177B3C54-32C7-4035-8DDA-602F4CF12936Q33911762-59B48595-C498-41B0-A057-7D765517345CQ37120148-B9CB081A-8E61-4A4A-BA22-A019E2482857Q38367630-520E5494-9B1A-4D58-B71A-78EF3C1A4089Q38514161-FBE0EA9F-5798-446A-AA42-0F010D59FD3CQ38584143-263FC005-B0A9-4C04-8104-3EFA3DF7299DQ38661567-0D316E75-59EE-40CB-99E0-0BDE550D7BA0Q38662413-C554E33E-27D9-4B09-B166-1F5ED844F9CBQ38805100-18FBB30F-6898-4CFC-B96C-51BB8E2A348BQ38846788-667F795A-F2D1-4A4C-B878-F6AB7373E2C1Q39035296-F8D3FE4C-769B-4DAB-B12A-14FD8CFE4C01Q39035338-3A2FA507-38DC-4613-875F-DFB811E7B8D1Q39446204-22F2CE97-BACB-41AB-B4FF-CE1E29CF1303Q39665406-EE054C6B-8742-4578-AEE7-6A9CDB0FA741Q40056971-19BD6FC6-0DF1-4203-931D-60DF8E1107E5Q40230660-5405E6F1-B0F5-44EA-8926-F86460D62C50Q48346122-BA4C8C34-1147-4B34-9959-A2C9515193A3Q52685085-71E30B93-B3C0-4A0A-859C-0A6561F6DAB1Q54942044-0EEF6760-8704-4A37-8D73-1BCF8C8CBCCCQ55229655-A54D539C-3E1C-4DDC-8DA6-77FB640C0F34
P2860
LpxC inhibitors as new antibacterial agents and tools for studying regulation of lipid A biosynthesis in Gram-negative pathogens.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
LpxC inhibitors as new antibac ...... is in Gram-negative pathogens.
@ast
LpxC inhibitors as new antibac ...... is in Gram-negative pathogens.
@en
LpxC inhibitors as new antibac ...... is in Gram-negative pathogens.
@nl
type
label
LpxC inhibitors as new antibac ...... is in Gram-negative pathogens.
@ast
LpxC inhibitors as new antibac ...... is in Gram-negative pathogens.
@en
LpxC inhibitors as new antibac ...... is in Gram-negative pathogens.
@nl
prefLabel
LpxC inhibitors as new antibac ...... is in Gram-negative pathogens.
@ast
LpxC inhibitors as new antibac ...... is in Gram-negative pathogens.
@en
LpxC inhibitors as new antibac ...... is in Gram-negative pathogens.
@nl
P2093
P2860
P356
P1433
P1476
LpxC inhibitors as new antibac ...... is in Gram-negative pathogens.
@en
P2093
Alita A Miller
Andrew P Tomaras
Arlene Carifa
Charlene Desbonnet
Craig J McPherson
David George
John P O'Donnell
Justin I Montgomery
Lisa Mullins
Matthew F Brown
P2860
P304
P356
10.1128/MBIO.01551-14
P577
2014-09-30T00:00:00Z